Del i serien Wiley Series on Drug Synthesis

Contemporary Drug Synthesis

Inbunden, Engelska, 2004

AvJie Jack Li,Douglas S. Johnson,Drago R. Sliskovic,Bruce D. Roth

2 379 kr

Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

An integrated and insightful look at successful drug synthesis in today's drug discovery market The pharmaceutical industry is unquestionably vibrant today, with drug synthesis making a vital contribution. Whether in the early developmental stages of identifying and optimizing a lead, or the latter stages of process development and cost-effective scale-up, the ability to design elegant and economical synthetic routes is often a major factor in the eventual viability and commercial success of a drug.Contemporary Drug Synthesis examines how leading researchers and manufacturers have integrated chemistry, biology, pharmacokinetics, and a host of other disciplines in the creation and development of leading drugs.Authored by four of the pharmaceutical industry's most respected scientists, this timely volume: Focuses on the processes that resulted in high-profile drugs including Lipitor, Celebrex, Viagra, Gleevec, Nexium, Claritin, and over a dozen othersProvides an in-depth introduction to each drug, followed by a detailed account of its synthesisOrganizes the drugs into fourteen therapeutic areas for clarity and ease of useProcess chemists provide an essential bridge between chemistry and the marketplace, creating scientifically practical drug processes while never losing sight of the commercial viability of those processes. Contemporary Drug Synthesis meets the needs of a growing community of researchers in pharmaceutical research and development, and is both a useful guide for practicing pharmaceutical scientists and an excellent text for medicinal and organic chemistry students.

Produktinformation

Utgivningsdatum2004-07-13
Mått196 x 236 x 20 mm
Vikt544 g
FormatInbunden
SpråkEngelska
SerieWiley Series on Drug Synthesis
Antal sidor240
FörlagJohn Wiley & Sons Inc
ISBN9780471214809

Tillhör följande kategorier

Tillverkningsteknik inom Naturvetenskap och teknik

Preface v Trade Names and Their Corresponding USANs xiAcronyms and Abbreviations xiiiChapter 1. Antithrombotics: Ticlopidine (Ticlid) and Clopidogrel (Plavix) 1Chapter 2. Anti-inflammatory Cyclooxygenase-2 Selective Inhibitors: Celecoxib (Celebrex) and Rofecoxib (Vioxx) 11Chapter 3. H+/K+ -ATPase Inhibitors: Esomeprazole (Nexium) 21Chapter 4. Protein-tyrosine Kinase Inhibitors: Imatnib (Gleevec) and Gefitinib (Iressa) 29Chapter 5. Non-sedating Antihistamines 39Chapter 6. Cosmeceuticals: Istretinoin (Accutane), Tazarotene (Tazorac), Minoxidil (Rogaine), and Finasteride (Propecia) 55Chapter 7. Antibacterials: Ciprofloxacin (Cipro) and Linezolid (Zyvox) 75Chapter 8. Atypical Antupsychotics 89Chapter 9. Atovastatin Calcium (Lipitor) 113Chapter 10. Antidepressants 125Chapter 11. Anti-obesity: Orlistat (Xenical) 149Chapter 12. Triptans for Migrane 161Chapter 13. PDE 5 Inhibitors for Erectile Dysfunction: Sildenafil (Viagra), Vardenafil (Levitra), and Tadalafil (Cialis) 189Chapter 14. Antiasthmatics 201Index 214

“…the authors have made an excellent selection of drugs and the coverage of the synthetic chemistry employed in their production is exemplary…” (Chemistry & Industry, 5th September 2005) "…a clear and easy to use reference for anyone working in drug discovery and development." (E-STREAMS, January 2005)"...a very useful book...for...pharmaceutical industry scientists...[and] the larger medicinal and organic chemistry community..." (Journal of Medicinal Chemistry, November 18, 2004)"…an outstanding primer on methods for chemical drug synthesis…the test is most useful, well written, and serves as a useful read for those interested in drug synthesis." (American Journal of Therapeutics, September/October 2004)“…highly interesting…keeps to the facts…” (http://www.organische-chemie.ch/)‘…I warmly recommend this book to synthetic organic chemists both in industry and in academia.' (Organic Process Research and Development Journal, July 2007)